tirzepatide slow responder Everyone wants to be a super to the GLP1s, most people are not. , Super responders are more sensitive to GLP1 medications often at lower doses and lose more weight than average. , And as a If semaglutide does not work

Many patients notice positive changes as early as the first few weeks

For patients experiencing persistent nausea , antiemetic medications may provide symptomatic relief, though these should be used under medical supervision: Metoclopramide a prokinetic agent that enhances gastric motility, but MHRA restricts use to short-term only (maximum 5 days) due to neurological side effect risks Domperidone another prokinetic with significant restrictions in the UK due to cardiac risks (QT prolongation)

It does not predict exact discontinuation outcomes but supports a more personalized provider conversation about your metabolic risk profile

FIGURE 3 8.4 Health economics and access: important implementation questions, but no PCOS-ART-specific economic evidence yet A structural tension exists between the clinical promise and the cost of GLP-1RAs